Future for assesment of drug safety, toxicology and efficacy

Sponsored By 

Speaker - Funded(s)

• 

  Abdullah Khan, BSc (Hons) MRes PhD

  Sir Henry Wellcome Fellow
  University of Oxford
  OXFORD, England, United Kingdom

Speaker - Not Funded(s)

• 

  Asli Akidil (she/her/hers)

  Scientific Liaison
  Emulate
  Boston, Massachusetts, United States
• 

  Marie Pierron, PhD

  Head of Bioassay development
  Nagi Bioscience
  SAINT-SULPICE, Switzerland

This session will look at the ways in which state-of-the-art in vitro systems can reduce the need for animal data in drug discovery and enhance the translational relevance of the early drug discovery process.

Presentations:

• 11:30 – 12:00 CEST

  Human bone marrow organoids as an alternative to animal models of blood cancer
  

  Abdullah O. Khan, BSc (Hons) MRes PhD – University of Oxford
• 12:00 – 12:30 CEST

  Innovating Drug Development: the Revolution of Organ-on-a-Chip Technology in Enhancing Safety and Efficacy Assessments
  

  Asli Akidil (she/her/hers) – Emulate
• 12:30 – 13:00 CEST

  Robotic device for fully automated high-content screening on C. elegans as a novel NAMs platform for early toxicity assessment
  

  Marie Pierron, PhD – Nagi Bioscience